Related Experiment Video
Updated: May 24, 2026
05:57
The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
Published on: May 17, 2024
Therapeutic potential of quercetin to decrease blood pressure: review of efficacy and mechanisms
Abigail J Larson1, J David Symons, Thunder Jalili
1Department of Nutrition, Exercise, and Health Science, Central Washington University, Ellensburg, WA, USA.
Advances in Nutrition (Bethesda, Md.)
|February 15, 2012
Summary
Quercetin, found in fruits and vegetables, may lower blood pressure. Research explores its potential as a natural therapeutic for cardiovascular health by examining its mechanisms of action.
Area of Science:
- Nutritional Science
- Cardiovascular Research
- Pharmacology
Background:
- Epidemiological studies link quercetin intake to reduced cardiovascular disease risk.
- Quercetin is a flavonoid abundant in plant-based foods like apples and berries.
- Recent studies show quercetin supplementation lowers blood pressure in hypertensive individuals.
Purpose of the Study:
- To review evidence for quercetin's therapeutic role in blood pressure reduction.
- To examine proposed mechanisms behind quercetin's antihypertensive effects.
Main Methods:
- Review of epidemiological studies and animal model research.
- Analysis of human studies on quercetin supplementation and blood pressure.
- Examination of proposed biochemical and physiological mechanisms.
Main Results:
- Consistent inverse relationship between quercetin intake and cardiovascular disease.
- Demonstrated blood pressure decrease in hypertensive subjects following quercetin supplementation.
- Identified potential mechanisms including antioxidant effects and ACE inhibition.
Conclusions:
- Quercetin shows promise as a natural agent for managing hypertension.
- Further human studies are needed to corroborate mechanisms observed in animal models.
- Quercetin's role in cardiovascular health warrants continued investigation.
Related Concept Videos
01:17Antihypertensive Drugs: Action of β1 Blockers
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
01:16Antihypertensive Drugs: Action of Diuretics
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
01:25Antihypertensive Drugs: Direct Renin Inhibitors
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...